Toxicity, Drug Clinical Trial
Official title:
Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning: A Randomized Controlled Clinical Trial
Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning.
The study aims to investigate the Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning: A Randomized Controlled Clinical Trial ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04916392 -
Observation Study of the Pharmacokinetics of Adductor Canal Block
|
||
Completed |
NCT04260113 -
Apatinib for Inoperable Advanced Chondrosarcoma
|
N/A | |
Recruiting |
NCT05355168 -
Neoadjuvant Chemoradiotherapy Combined With Camrelizumab and Nimotuzumab for Esophageal Squamous Cell Carcinoma
|
Phase 1/Phase 2 | |
Recruiting |
NCT04351308 -
Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma
|
Phase 2 | |
Active, not recruiting |
NCT03638375 -
TIL and Anti-PD1 in Metastatic Melanoma
|
Phase 1/Phase 2 | |
Recruiting |
NCT05652673 -
Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
|
N/A | |
Recruiting |
NCT05512169 -
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
|
||
Completed |
NCT04690231 -
Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma
|
N/A | |
Completed |
NCT02719002 -
Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials
|
N/A | |
Suspended |
NCT04824352 -
Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma
|
Phase 2 |